Please login to the form below

Not currently logged in
Email:
Password:

mCNV

This page shows the latest mCNV news and features for those working in and with pharma, biotech and healthcare.

Lucentis claims speedy FDA review for myopia complication

Lucentis claims speedy FDA review for myopia complication

Eylea is not yet approved for mCNV in the US, although Bayer has a green light for this use in Europe and so is already competing head-to-head with Novartis

Latest news

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics